Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1217095.RAlACslUsAPifrf40OVefLGe-Kzcht_lfyMTjZFzbejdc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1217095.RAlACslUsAPifrf40OVefLGe-Kzcht_lfyMTjZFzbejdc130_assertion type Assertion NP1217095.RAlACslUsAPifrf40OVefLGe-Kzcht_lfyMTjZFzbejdc130_head.
- NP1217095.RAlACslUsAPifrf40OVefLGe-Kzcht_lfyMTjZFzbejdc130_assertion description "[Thus, we examined PLA2R1 expression in primary prostate cells (PCS-440-010) and human prostate cancer cells (LNCaP, DU-145, and PC-3), and we determined the effect of PLA2R1 knockdown on cytotoxicity induced by free or liposome-encapsulated chemotherapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217095.RAlACslUsAPifrf40OVefLGe-Kzcht_lfyMTjZFzbejdc130_provenance.
- NP1217095.RAlACslUsAPifrf40OVefLGe-Kzcht_lfyMTjZFzbejdc130_assertion evidence source_evidence_literature NP1217095.RAlACslUsAPifrf40OVefLGe-Kzcht_lfyMTjZFzbejdc130_provenance.
- NP1217095.RAlACslUsAPifrf40OVefLGe-Kzcht_lfyMTjZFzbejdc130_assertion SIO_000772 25189995 NP1217095.RAlACslUsAPifrf40OVefLGe-Kzcht_lfyMTjZFzbejdc130_provenance.
- NP1217095.RAlACslUsAPifrf40OVefLGe-Kzcht_lfyMTjZFzbejdc130_assertion wasDerivedFrom befree-2016 NP1217095.RAlACslUsAPifrf40OVefLGe-Kzcht_lfyMTjZFzbejdc130_provenance.
- NP1217095.RAlACslUsAPifrf40OVefLGe-Kzcht_lfyMTjZFzbejdc130_assertion wasGeneratedBy ECO_0000203 NP1217095.RAlACslUsAPifrf40OVefLGe-Kzcht_lfyMTjZFzbejdc130_provenance.